Z80

3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine

Z80 as a free ligand exists in 9 entries. Examples include: 3LK0 5G08 5NUK

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine
Identifiers3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine
FormulaC17 H19 Cl N2 S
Molecular Weight318.86
TypeNON-POLYMER
Isomeric SMILESCN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc12
InChIInChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3
InChIKeyZPEIMTDSQAKGNT-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count40
Chiral Atom Count0
Chiral Atomsn/a
Bond Count42
Aromatic Bond Count12
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00477 Different stereochemistry
NameChlorpromazine
Groups
  • approved
  • vet_approved
DescriptionThe prototypical phenothiazine antipsychotic drug. Like the other drugs in this class, chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking dopamine receptors. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. [PubChem]
Synonyms
  • 3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine
  • 3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine
  • Aminazine
  • Chlorderazin
  • Chloropromazine
SaltsChlorpromazine hydrochloride
Brand Names
  • Apo Chlorpromazine
  • Chlorprom Tab 100mg
  • Chlorprom Tab 25mg
  • Chlorprom Tab 50mg
  • Chlorpromanyl 20 Syr
Affected OrganismHumans and other mammals
IndicationFor the treatment of schizophrenia, control nausea and vomiting, For relief of restlessness and apprehension before surgery, adjunct in the treatment of tetanus, control the manifestations of the manic type of manic-depressive illness.
PharmacologyChlorpromazine is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Chlorpromazine has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Chlorpromazine has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.
Mechanism of actionChlorpromazine acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects). Additionally, Chlorpromazine is a weak presynaptic inhibitor of Dopamine reuptake, which may lead to (mild) antidepressive and antiparkinsonian effects. This action could also account for psychomotor agitation and amplification of psychosis (very rarely noted in clinical use).
Route of administration
  • Intramuscular
  • Intramuscular; Intravenous
  • Oral
  • Rectal
Categories
  • Alpha1 Antagonists
  • Antiemetics
  • Antipsychotic Agents
  • Antipsychotic Agents (First Generation [Typical])
  • Autonomic Agents
ATC-CodeN05AA01
AHFS-Code28:16.08.24
CAS number50-53-3

Drug Targets

NameSequence SearchPharmacological ActionActions
Alpha-1D adrenergic receptorMTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGA...unknown
Alpha-1D adrenergic receptorMTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGA...unknown
Alpha-1D adrenergic receptorMTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGA...unknown
Alpha-1-acid glycoprotein 2MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDRITGKWFYIASAF...unknownbinder
5-hydroxytryptamine receptor 1AMDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCA...yesantagonist
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682